TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways

Circulation

Volumn 107, Issue 17, 2003, Pages 2250-2256

  Secchiero, Paola ^a,d   Gonelli, Arianna ^a   Carnevale, Edvige ^b   Milani, Daniela ^a   Pandolfi, Assunta ^c   Zella, Davide ^d   Zauli, Giorgio ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

Endothelium; Inflammation; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CASPASE; CELL MARKER; DEATH RECEPTOR 4; DEATH RECEPTOR 5; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PARTHENOLIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; RECEPTOR SUBTYPE; SYNAPTOPHYSIN; TRAIL RECEPTOR 3; TRAIL RECEPTOR 4; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AORTA; AORTA MEDIA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; CYTOLOGY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREACTIVITY; INFLAMMATION; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; REGULATORY MECHANISM; SMOOTH MUSCLE; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL ADHESION MOLECULES; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038414629     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000062702.60708.C4     Document Type: Article

References (23)

1. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene. 1996;12:1-9.
2. Mariani SM, Krammer PH. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol. 1998;28:973-982.
3. Sheridan JP, Marsters SA, Pitti PM, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science. 1997; 277:818-822.
4. Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med. 1999; 5:157-163.
5. Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest. 1999;104:155-162.
6. Zhang XD, Nguyen T, Thomas WD, et al. Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett. 2000;482:193-199.
7. Gochuico BR, Zhang J, Ma BY, et al. TRAIL expression in vascular smooth muscle. Am J Physiol. 2000;278:L1045-L1050.
8. Chapman HA, Riese RJ, Shi GP. Emerging roles for cysteine proteases in human biology. Annu Rev Physiol. 1997;59:63-88.
9. Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 1995;9:899-909.
10. Secchiero P, Gonelli A, Celeghini C, et al. Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. Blood. 2001;98:2220-2228.
11. Madge LA, Pober JS. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFκB in human endothelial cells. J Biol Chem. 2000; 275:15458-15465.
12. Lee SE, Chung WJ, Kwak HB, et al. Tumor necrosis factor-α supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem. 2001;276:49343-49349.
13. Hagemann C, Blank JL. The ups and downs of MEK kinase interactions. Cell Signal. 2001;13:863-875.
14. Fruman DA, Meyers RE, Cantley LC. Phosphoinositide kinases. Annu Rev Biochem. 1998;67:481-507.
15. Suhara T, Mano T, Oliveira BE, et al. Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res. 2001;89:13-19.
16. Yu Y, Sato JD. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of endothelial cells to vascular endothelial growth factor. J Cell Physiol. 1999;178:235-246.
17. Laird SM, Graham A, Paul A, et al. Tumor necrosis factor stimulates stress-activated protein kinases and the inhibition of DNA synthesis in cultures of bovine aortic endothelial cells. Cell Signal. 1998;10:473-480.
18. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3:221-227.
19. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389-395.
20. Jones RG, Elford AR, Parsons MJ, et al. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J Exp Med. 2002;196:335-348.
21. Lynch CN, Wang YC, Lund JK, et al. TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem. 1999;274:8455-8459.
22. Jakubowski A, Browning B, Lukashev M, et al. Dual role for TWEAK in angiogenic regulation. J Cell Sci. 2002;115:267-274.
23. Brogi E, Wu T, Namiki A, et al. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation. 1994; 90:649-652.